This action of CHAC1, known as the “blocker of NOTCH,” effectively reduces the cell surface expression of the full-length NOTCH1 receptor, thus inhibiting the NOTCH1 signaling pathway and contributing to the suppression of T-ALL cell viability (Chang Soo et al., 2023). Here, CHAC1 is linked to acute lymphoblastic leukemia.